CrowdPharm and Avlis International announced on Thursday a partnership around branded communications targeted at physicians and specialty pharma. Based in California, Avlis brings events/meetings and med-ed expertise to the growing CrowdPharm arsenal.
“Our goal has always been to develop innovative programs and events that will generate interest and engagement,” said Avlis CEO Sue Silva in a statement. “We understand healthcare providers have endless choices when it comes to consuming medical content. We strive to create dynamic programming options that foster learning in unique and effective ways.”
The announcement comes at the end of a busy 2021 for CrowdPharm. The firm merged with fellow independent agency Cross & Wild in September and partnered with Bernstein-Rein earlier in the year. According to MM+M’s 2021 Agency 100, CrowdPharm generated $2 million in revenue during 2020.
